TapewireFind a company

person · Reporting owner

Ganot Ilan

Disclosed activity across 1 company

Tapewire entity
39287
SEC CIK
0001727460

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Solid Biosciences Inc.SLDB · Entity 4915DirectorJune 10, 2026June 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Solid Biosciences Inc.

Report date June 10, 2026 · Filed June 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.61 · Expires 2036-06-10Direct77,500 Reported balance After 2026-06-10 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-10 · Grant · Acquired 77,500 · Balance 77,500

F1: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Filing footnotes · ownership attribution and instrument terms

F1: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 11, 2026 20:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantDirector Stock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $6.61 $0.00
Disclosure

SEC source: 0001193125-26-267502 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2036-06-10

F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 02:32 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 2,658 $5.82 $15,478.33
Disclosure

SEC source: 0001193125-26-057868 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 27,474

F3 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 02:32 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 4,861 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057868 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 9,722

Underlying: Common Stock · 4,861 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F6 · derivative.expiration_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
February 13, 2026 Filed Feb 19, 2026 02:32 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 4,861 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057868 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 30,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 23:01 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 7,205 $6.44 $46,413.89
Disclosure

SEC source: 0001193125-26-041516 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 25,271

F1 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:07 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 45,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary

F6 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:07 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 15,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 32,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:07 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantRestricted Stock Units · Derivative 35,450 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 35,450

Underlying: Common Stock · 35,450 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F5 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:07 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantEmployee Stock Option (Right to Buy) · Derivative 70,900 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 4

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 70,900

Underlying: Common Stock · 70,900 shares

Expires 2036-01-29

F4 · derivative.exercise_date: This option was granted on January 29, 2026 (the "2026 Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 28, 2026 Filed Jan 30, 2026 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 191 $6.59 $1,258.69
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 17,476

F2 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 3,884 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,884 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F6 · derivative.expiration_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 389 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 0

Underlying: Common Stock · 389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 3,884 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 3

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.direct: Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 389 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 17,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 23:52 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 1,053 $5.43 $5,717.79
Disclosure

SEC source: 0001193125-26-004953 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 17,278

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 03, 2026 Filed Jan 6, 2026 23:52 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 2,994 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-004953 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 2,994

Underlying: Common Stock · 2,994 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 03, 2026 Filed Jan 6, 2026 23:52 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 2,994 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-004953 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 18,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common stock on a one-for-one basis.

Read SEC document
November 10, 2025 Filed Nov 13, 2025 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 3,278 $4.12 $13,505.36
Disclosure

SEC source: 0001193125-25-280126 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,412

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

F2 · balance_after: Represents 91,370 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:25 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantRestricted Stock Units · Derivative 18,750 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-109749 · ownership.xml · derivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F1 · derivative.exercise_date: The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

F1 · derivative.expiration_date: The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:25 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantEmployee Stock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $6.17 $0.00
Disclosure

SEC source: 0000950170-25-109749 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-08-14

F1 · derivative.exercise_date: The RSUs (as defined in footnote 2) together with this option were granted on August 14, 2025 (the "Grant Date") and vest over four years, with 50% of the original number of shares vesting on the second anniversary of the Grant Date and 25% of the original number of shares annually thereafter until the fourth such anniversary.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:25 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantDirector Stock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $4.58 $0.00
Disclosure

SEC source: 0000950170-25-086234 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2035-06-12

F1 · derivative.exercise_date: This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 1,711 $3.96 $6,775.56
Disclosure

SEC source: 0000950170-25-022199 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 14,839

F3 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 4,861 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-022199 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 14,583

Underlying: Common Stock · 4,861 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 4,861 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-022199 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 16,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 31, 2025 Filed Feb 11, 2025 21:42 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantRestricted Stock Units · Derivative 60,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-017977 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F2 · derivative.expiration_date: The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
January 28, 2025 Filed Jan 29, 2025 23:14 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 144 $3.11 $447.78
Disclosure

SEC source: 0000950170-25-010625 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 11,689

F2 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:14 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 3,883 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-010625 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,884

Underlying: Common Stock · 3,883 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F6 · derivative.expiration_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:14 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 388 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-010625 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 389

Underlying: Common Stock · 388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:14 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 3,883 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-010625 · ownership.xml · nonDerivative · entry 3

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.direct: Represents 94,648 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document
January 27, 2025 Filed Jan 29, 2025 23:14 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 388 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-010625 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 11,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 06, 2025 Filed Jan 7, 2025 22:29 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 1,056 $4.31 $4,551.36
Disclosure

SEC source: 0000950170-25-003054 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 11,445

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:29 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 2,994 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-003054 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 5,988

Underlying: Common Stock · 2,994 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 22:29 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 2,994 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-003054 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 12,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common stock on a one-for-one basis.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:05 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantDirector Stock Option (Right to Buy) · Derivative 34,400 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0000950170-24-072992 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,400

Underlying: Common Stock · 34,400 shares

Expires 2034-06-11

F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 1,553 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 0

Underlying: Common Stock · 1,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.

F5 · derivative.expiration_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024.

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 462 $10.33 $4,772.46
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 9,507

F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units. This sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
May 02, 2024 Filed May 6, 2024 22:48 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 1,553 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 9,969

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 15:50 UTC Solid Biosciences Inc. SLDB · Entity 4915 GrantRestricted Stock Units · Derivative 19,444 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-016180 · ownership.xml · derivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 19,444

Underlying: Common Stock · 19,444 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

F2 · derivative.expiration_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2024 Filed Jan 30, 2024 22:20 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 139 $7.99 $1,110.61
Disclosure

SEC source: 0000950170-24-008971 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 8,416

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 27, 2024 Filed Jan 30, 2024 22:20 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 3,883 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-008971 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,767

Underlying: Common Stock · 3,883 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On the grante date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F6 · derivative.expiration_date: On the grante date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2024 Filed Jan 30, 2024 22:20 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 388 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-008971 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 777

Underlying: Common Stock · 388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2024 Filed Jan 30, 2024 22:20 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 3,883 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-008971 · ownership.xml · nonDerivative · entry 3

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.direct: Represents 90,765 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document
January 27, 2024 Filed Jan 30, 2024 22:20 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 388 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-008971 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 8,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 00:04 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 2,993 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-002599 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 8,982

Underlying: Common Stock · 2,993 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 00:04 UTC Solid Biosciences Inc. SLDB · Entity 4915 SaleCommon Stock 1,142 $5.30 $6,052.49
Disclosure

SEC source: 0000950170-24-002599 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 8,167

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 03, 2024 Filed Jan 6, 2024 00:04 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 2,993 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-002599 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Wife

Disclosed balance after: 9,309

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common stock on a one-for-one basis.

Read SEC document
December 02, 2023 Filed Dec 5, 2023 19:33 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 1,583 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-068068 · ownership.xml · derivative · entry 4

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,583 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to common on a one-for-one basis.

F5 · derivative.exercise_date: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.

F5 · derivative.expiration_date: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.

Read SEC document
December 02, 2023 Filed Dec 5, 2023 19:33 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 1,583 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-068068 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to common on a one-for-one basis.

F2 · ownership.direct: Represents 86,882 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document
September 02, 2023 Filed Sep 6, 2023 20:40 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionRestricted Stock Units · Derivative 1,583 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-046760 · ownership.xml · derivative · entry 4

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,583

Underlying: Common Stock · 1,583 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.

F5 · derivative.expiration_date: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.

Read SEC document
September 02, 2023 Filed Sep 6, 2023 20:40 UTC Solid Biosciences Inc. SLDB · Entity 4915 Exercise / conversionCommon Stock 1,583 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-046760 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · ownership.direct: Represents 85,299 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.